MS

Mahadev Siddamallappa Bangalore

Director Whole-Time Director DIN 02894771
DIN 02894771 First appointment Dec 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Dec 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahadev Siddamallappa Bangalore

Data last updated:

Mahadev Siddamallappa Bangalore was a Whole-Time Director at Group Pharmaceuticals Limited (2009–2013). The company operates in Pharma.

DIN 02894771
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 02 Dec 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Group Pharmaceuticals Limited U24239MH1980PLC022889
Whole-Time Director02 Dec 20091980₹168 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Group Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Mahadev Siddamallappa Bangalore

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahadev Siddamallappa Bangalore

Mahadev Siddamallappa Bangalore was first appointed on 02 Dec 2009 as Whole-Time Director at Group Pharmaceuticals Limited.

Mahadev Siddamallappa Bangalore held 1 earlier board appointment: Group Pharmaceuticals Limited (Whole-Time Director, 02 Dec 2009 to 10 Mar 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available